Findings Support Individualized Glycemic Control in T2DM

Share this content:
Findings Support Individualized Glycemic Control in T2DM
Findings Support Individualized Glycemic Control in T2DM

TUESDAY, Dec. 12, 2017 (HealthDay News) -- An individualized approach to glycemic control in type 2 diabetes is likely to reduce costs and improve quality of life, according to a study published online Dec. 12 in the Annals of Internal Medicine.

Neda Laiteerapong, M.D., from the University of Chicago, and colleagues estimated the cost-effectiveness of individualized versus uniform intensive control for the U.S population with type 2 diabetes. Data were obtained from the National Health and Nutrition Examination Survey 2011 to 2012.

The researchers found that, compared with uniform intensive control, individualized control saved $13,547 per patient ($105,307 versus $118,854), mainly due to reduced medication costs ($34,521 versus $48,763). Decreased life expectancy was seen with individualized control (20.63 versus 20.73 years) due to an increase in complications; however, there was an increase in quality-adjusted life-years (QALYs: 16.68 versus 16.58) resulting from fewer hypoglycemic events and fewer medications. In sensitivity analyses, individualized control was found to be cost-saving and generated more QALYs versus intensive control, except in analysis in which there was at least a 60 percent reduction in disutility associated with receiving diabetes medication.

"Health policies and clinical programs that encourage an individualized approach to glycemic control for U.S. adults with type 2 diabetes reduce costs and increase quality of life compared with uniform intensive control," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

CDC Identifies Drugs Frequently Involved in Drug Overdose Deaths

CDC Identifies Drugs Frequently Involved in Drug Overdose ...

Oxycodone, heroin, and fentanyl ranked first in 2011, 2012-2015, 2016; cocaine ranked second or third

2017 Saw Slowing in National Health Care Spending

2017 Saw Slowing in National Health Care Spending

Slower growth in health care spending mainly due to use and intensity of goods and services

Inflammatory Bowel Disease, Prostate Cancer Linked

Inflammatory Bowel Disease, Prostate Cancer Linked

At age 60, men with inflammatory bowel disease have higher values of prostate-specific antigen

is free, fast, and customized just for you!




Already a member?

Sign In Now »